Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China renews Bt rice biosafety certificates

China’s Ministry of Agriculture has renewed biosafety certificates for the country’s only two approved strains of Chinese-developed genetically modified pest-resistant Bt rice, Huahui No1 and Bt Shanyou 63, and for the transgenic phytase maize, BVLA430101, reports the China Crop Protection Industry Association (CCPIA). The new biosafety certificates were reportedly issued in December 2014, and will be valid for a period of five years. Both rice strains were developed by China’s Huazhong Agricultural University, while the phytase maize was developed by the Chinese Academy of Agricultural Sciences. The previous safety certificates, issued in 2009, expired in August 2014, amid much speculation as to the possibility of renewal . Both strain of Bt rice are only approved for trials in Hubei province. Nevertheless, the CCPIA reports prominent researchers as suggesting that if the government did not permit commercialisation of the technology then having the biosafety certificates would be like “holding a blank piece of paper”.

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AG021656

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel